Rating History for Monte Rosa Therapeutics (GLUE) by TD Cowen
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/22/2026 | Tyler Van Buren | New Coverage | Buy (N/A) |
N/A (N/A) |
14.78 (14.31) |
-3.18% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 8/22/2026 | Tyler Van Buren | New Coverage | Buy (N/A) |
N/A (N/A) |
14.78 (14.31) |
-3.18% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||